Charisse R. Lillie - 28 Apr 2026 Form 4 Insider Report for EXELON CORP (EXC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Apr 2026, 16:05:17 UTC
Prior SEC filing
01 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
David T. Skinner, attorney-in-fact for Charisse R Lillie

Key filing fact

Charisse R. Lillie filed Form 4 for EXELON CORP (EXC) on 29 Apr 2026.

Key facts

  • This page summarizes Charisse R. Lillie's Form 4 filing for EXELON CORP (EXC).
  • 1 reported transaction and 2 derivative rows are listed below.
  • Accepted by SEC: 29 Apr 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 01 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001972789 Primary reporting owner

Lillie Charisse R

Relationship
Director
Address
10 S DEARBORN STREET, 54TH FLOOR, CHICAGO
Signature
David T. Skinner, attorney-in-fact for Charisse R Lillie
Signature date
29 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXC transaction Derivative

2026 Directors Restricted Stock Units

Award

Transaction value
Shares
+3,720
Change %
Price
$0.000000*
Shares after
3,720
Date
28 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,720
Exercise price
Footnotes
F1
EXC holding Derivative

Deferred phantom share equivalents

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,855
Date
28 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,855
Exercise price
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Annual restricted stock unit (RSU) award subject to the Exelon Long-term Incentive Plan (LTIP) will fully vest and be settled in shares of Exelon common stock on a 1 for 1 basis. The award will accrue additional stock units through dividend reinvestment which will vest along with the underlying award.

Footnote F2

Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .